Default company panoramic image
546edb50 16ab 42d8 8a43 397c23fc5eec

Rubigo Therapeutics, Inc.

Rubigo Therapeutics has a unique polymer technology that enables delivery of chemicals in regulated and non-regulated markets.

  • Stage Prototype Ready
  • Industry Sports
  • Location St Paul, MN, USA
  • Currency USD
  • Founded September 2011
  • Employees 2

Company Summary

Rubigo is a platform technology company with an exciting, disruptive technology for the sports fishing market. Technology enables fresh and salt water fishermen to use natural or synthetic pheromones (scents) to enhance their fishing experience for either recreation or competition. Rubigo initially targeted an improved delivery of an existing FDA approved drug for skin cancer now focused on this unique opportunity for 2013 commercialization.


  • Default avatar
    Kevin L Nickels

    Has held multiple GM roles in life science & aerospace companies. After monetizing his 1st startup thru a sale to Orthofix, he turned around Celleration, a VC backed company developing and then, commercializing a new technology in the wound care, tissue regeneration market. Under his leadership, technology was developed, FDA approved, clinically validated, obtained a unique CPTcode, dedicated reimbursement and achieved 4th yr sales of $10MM.

  • Default avatar
    Stanley D Harpstead

    Has held positions in the Life Science market in marketing and R&D. After leaving Dacomed, he joined Medtronic’s Neurological Division to market spinal cord stimulation products for chronic pain and developed new therapeutic markets utilizing nerve stimulation. He co-founded RST in 2000, a privately held developer of an implanted medical device for implanted cell cultures and later, a wound barrier film leading to the patent applications.


  • Default avatar
    Lommen, Abdo, Cole, King & Stageberg, P.A.
    Default avatar
    Olsen Theilen

Previous Investors

  • Default avatar
    Default avatar
    Angel Investors